Ironjustic
Thu, Mar-20-08, 05:17
Sooo .. would this be .. again .. simply the chaff of your
grain .. ? Niacin and an iron chelator ..
"Seventeen patients". "Thirteen subjects achieved normal
levels of cholesterol"
Title: New combined therapy of niceritrol and probucol on
heterozygous familial hypercholesterolemia. Author:
Yamamoto, K : Fukushima, N : Ozaki, I : Setoguchi, Y :
Yanagita, T : Sakai, T Citation: Artery. 1991; 18(3): 133-49
Abstract: Seventeen patients with heterozygous familial
hypercholesterolemia were sequentially treated with: a low
cholesterol, fat restricted diet; diet and probucol (500
mg/day); and diet, probucol and niceritrol (1500 mg/day).
Concentrations of plasma cholesterol decreased from 348 + 49
mg/dl on diet alone to 304 + 32 mg/dl, to 256 + 30 mg/dl on
diet and probucol, and fell to 212 + 41 mg/dl on the
combined regimen with niceritrol. Concentrations of
LDL-cholesterol declined 13% on diet, and 26% on diet and
probucol; the subsequent addition of niceritrol resulted in
a 42% fall from the baseline. Plasma concentrations of
apolipoprotein B fell 37% on the combined regimen with
niceritrol. As a result, normal levels of cholesterol (less
than 230 mg) were achieved in thirteen subjects treated with
this new combination therapy. Moreover, atherogenic index
improved with the addition of niceritrol. These results
suggest even a small dose of niceritrol affords opportunity
to maintain normal lipid profile in heterozygous familial
hypercholesterolemia when given in combination with
probucol. Review References: None Notes: None Language:
English Publication Type: Journal-Article Keywords:
Hypercholesterolemia, Familial drug therapy : Niceritrol
therapeutic use : Probucol therapeutic use
----------------------------------
http://tinyurl.com/ynpdhm
"Iron-chelating agents, N-acetyl-L-cysteine (NAC),
apocynin,probucol, and edaravone, are useful in preventing
cardiovascular injury and diseases."
Recent Patents on Anti-Infective Drug Discovery, 2006, 1,
17-31171574-891X/06 $100.00+.00(c) 2006 Bentham Science
Publishers Ltd.Recent Progress in Pharmacological Research of
Antioxidants inPathological Conditions: Cardiovascular Health
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING http://tinyurl.com/zk9fk
.
grain .. ? Niacin and an iron chelator ..
"Seventeen patients". "Thirteen subjects achieved normal
levels of cholesterol"
Title: New combined therapy of niceritrol and probucol on
heterozygous familial hypercholesterolemia. Author:
Yamamoto, K : Fukushima, N : Ozaki, I : Setoguchi, Y :
Yanagita, T : Sakai, T Citation: Artery. 1991; 18(3): 133-49
Abstract: Seventeen patients with heterozygous familial
hypercholesterolemia were sequentially treated with: a low
cholesterol, fat restricted diet; diet and probucol (500
mg/day); and diet, probucol and niceritrol (1500 mg/day).
Concentrations of plasma cholesterol decreased from 348 + 49
mg/dl on diet alone to 304 + 32 mg/dl, to 256 + 30 mg/dl on
diet and probucol, and fell to 212 + 41 mg/dl on the
combined regimen with niceritrol. Concentrations of
LDL-cholesterol declined 13% on diet, and 26% on diet and
probucol; the subsequent addition of niceritrol resulted in
a 42% fall from the baseline. Plasma concentrations of
apolipoprotein B fell 37% on the combined regimen with
niceritrol. As a result, normal levels of cholesterol (less
than 230 mg) were achieved in thirteen subjects treated with
this new combination therapy. Moreover, atherogenic index
improved with the addition of niceritrol. These results
suggest even a small dose of niceritrol affords opportunity
to maintain normal lipid profile in heterozygous familial
hypercholesterolemia when given in combination with
probucol. Review References: None Notes: None Language:
English Publication Type: Journal-Article Keywords:
Hypercholesterolemia, Familial drug therapy : Niceritrol
therapeutic use : Probucol therapeutic use
----------------------------------
http://tinyurl.com/ynpdhm
"Iron-chelating agents, N-acetyl-L-cysteine (NAC),
apocynin,probucol, and edaravone, are useful in preventing
cardiovascular injury and diseases."
Recent Patents on Anti-Infective Drug Discovery, 2006, 1,
17-31171574-891X/06 $100.00+.00(c) 2006 Bentham Science
Publishers Ltd.Recent Progress in Pharmacological Research of
Antioxidants inPathological Conditions: Cardiovascular Health
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING http://tinyurl.com/zk9fk
.